X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (182) 182
Publication (14) 14
Book / eBook (7) 7
Newspaper Article (7) 7
Patent (3) 3
Book Chapter (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (112) 112
female (102) 102
oncology (99) 99
middle aged (89) 89
adult (75) 75
breast cancer (74) 74
aged (68) 68
breast neoplasms - drug therapy (67) 67
breast neoplasms - pathology (62) 62
index medicus (61) 61
chemotherapy (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
cancer (40) 40
treatment outcome (29) 29
prognosis (25) 25
breast neoplasms - genetics (24) 24
therapy (24) 24
doxorubicin - administration & dosage (23) 23
research (22) 22
survival (22) 22
breast neoplasms - metabolism (20) 20
doxorubicin (20) 20
disease-free survival (19) 19
gene expression (19) 19
metastasis (19) 19
care and treatment (18) 18
neoplasm metastasis (18) 18
trial (18) 18
cyclophosphamide - administration & dosage (17) 17
survival analysis (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
drug administration schedule (16) 16
fluorouracil - administration & dosage (16) 16
gene expression profiling (16) 16
immunohistochemistry (16) 16
paclitaxel (16) 16
research article (16) 16
tumors (16) 16
women (16) 16
dose-response relationship, drug (15) 15
trastuzumab (15) 15
breast neoplasms - surgery (14) 14
carcinoma (14) 14
chemotherapy, adjuvant (14) 14
gene expression regulation, neoplastic (14) 14
genetic aspects (14) 14
male (14) 14
breast neoplasms - mortality (13) 13
combined modality therapy (13) 13
genes (13) 13
neoadjuvant therapy (13) 13
neoplasm staging (13) 13
docetaxel (12) 12
antineoplastic agents - therapeutic use (11) 11
article (11) 11
cyclophosphamide (11) 11
doxorubicin - adverse effects (11) 11
medicine & public health (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
breast-cancer (10) 10
expression (10) 10
paclitaxel - administration & dosage (10) 10
receptor, erbb-2 - metabolism (10) 10
aged, 80 and over (9) 9
analysis (9) 9
breast carcinoma (9) 9
breast neoplasms - therapy (9) 9
cell line, tumor (9) 9
follow-up studies (9) 9
health aspects (9) 9
kaplan-meier estimate (9) 9
medicine (9) 9
neoadjuvant chemotherapy (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
predictive value of tests (9) 9
prospective studies (9) 9
abridged index medicus (8) 8
animals (8) 8
anthracyclines (8) 8
antineoplastic agents, phytogenic - adverse effects (8) 8
antineoplastic agents, phytogenic - therapeutic use (8) 8
cancer research (8) 8
cancer therapies (8) 8
diagnosis (8) 8
drug resistance, neoplasm (8) 8
medical prognosis (8) 8
medical research (8) 8
metastatic breast cancer (8) 8
oligonucleotide array sequence analysis (8) 8
paclitaxel - adverse effects (8) 8
paclitaxel - therapeutic use (8) 8
patient outcomes (8) 8
patients (8) 8
pharmacology & pharmacy (8) 8
preoperative chemotherapy (8) 8
receptors, estrogen - analysis (8) 8
taxoids - administration & dosage (8) 8
time factors (8) 8
biomarkers (7) 7
breast neoplasms - radiotherapy (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4111 - 4119
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 23, pp. 3126 - 3132
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2005, Volume 23, Issue 25, pp. 5983 - 5992
Journal Article
Cancer, ISSN 0008-543X, 05/2005, Volume 103, Issue 9, pp. 1763 - 1769
BACKGROUND Accurate assessment of HER‐2 status is necessary prior to anti‐HER‐2 antibody (trastuzumab) therapy for metastatic breast carcinoma. However,... 
fluorescence in situ hybridization | HER‐2 | breast carcinoma | metastasis | chemotherapy | primary | Breast carcinoma | Chemotherapy | Metastasis | HER-2 | Fluorescence in situ hybridization | Primary | PROTEIN OVEREXPRESSION | MONOCLONAL-ANTIBODY | ADJUVANT THERAPY | CANCER | TOPOISOMERASE II-ALPHA | C-ERBB-2 EXPRESSION | ERBB-2 | ONCOGENE | ONCOLOGY | GENE AMPLIFICATION | Carcinoma, Ductal, Breast - genetics | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Antineoplastic Agents - therapeutic use | Chromosomes, Human, Pair 17 - genetics | Paraffin Embedding | Carcinoma, Ductal, Breast - drug therapy | Carcinoma, Lobular - genetics | Sensitivity and Specificity | Adult | Female | Retrospective Studies | Liver Neoplasms - secondary | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | Liver Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Biomarkers, Tumor - analysis | Liver Neoplasms - drug therapy | In Situ Hybridization, Fluorescence | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Gene Amplification | Breast Neoplasms - pathology | Neoplasm Recurrence, Local - genetics | Aged | Carcinoma, Lobular - drug therapy | Biopsy, Needle | Neoplasm Staging | Usage | Development and progression | Breast cancer | Diagnosis | Cancer
Journal Article
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 05/2011, Volume 305, Issue 18, pp. 1873 - 1881
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 3, pp. 628 - 633
Journal Article